Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...
Reexamination Certificate
2002-12-12
2010-06-22
Falk, Anne-Marie (Department: 1632)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
C435S320100
Reexamination Certificate
active
07741112
ABSTRACT:
The present invention provides compositions and methods for direct transfection of mitochondria and chloroplast DNA in living cells. More particularly, the present invention is based on the use of viral vectors that specifically bind to receptors uniquely found on the target organelle. In one embodiment, as shown inFIG. 1, a eukaryotic cell containing an organelle (1) that has been modified to express a viral receptor (2) on the organelle's surface is provided. A viral vector (6) comprising a desired recombinant DNA construct (3) is introduced into the cytosol of the cell, wherein the viral vector binds to its receptor and introduces the recombinant DNA into the interior of the organelle.
REFERENCES:
patent: 5831020 (1998-11-01), Citovsky
patent: 5854414 (1998-12-01), Hillman et al.
patent: 2007/0011759 (2007-01-01), Khan
patent: 2272788 (2000-12-01), None
patent: WO 98/46271 (1998-10-01), None
patent: WO 00/19993 (2000-04-01), None
Shore et al, (Eur J Biochem, 227: 9-18, 1995.
Ghosh et al, (Gene Expr, 7(3): 1-2, 1998.
Owen et al, (Human Gene Therapy, 11: 2067-2078, 2000.
de Grey et al, (TIBTECH, 18: 394-399, 2000).
Tommassen et al, (Mol Gen Genet , 197: 503-508, 1984).
D'Souza, G. , et al., “Gene Therapy of the other Genome : The Challenges of treating Mitochondrial DNA Defects”,Pharm Res.,24(2), Epub Dec. 19, 2006,(Feb. 2007),228-38.
Khan, S. M., et al., “Development of mitochondrial gene Replacement Therapy”,J Bioenerg Biomembr.,36(4), XP019280561,(Aug. 2004),387-93.
Maliga, P. , et al., “Plant biotechnology 2007: all three genomes make contributions to progress”,Current Opinion in Biotechnology,18(2), (Apr. 17, 2007),97-99.
Wallace, D. C., et al., “The mitochondrial genome in human adaptive radiation and disease: on the road to therapeutics and performance enhancement.”,Gene,354, XP005019916,(Jul. 18, 2005),169-80.
Falk Anne-Marie
Schwegman Lundberg & Woessner, P.A.
Sgagias Magdalene K
University of Virginia Patent Foundation
LandOfFree
Vector mediated organelle transfection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vector mediated organelle transfection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vector mediated organelle transfection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4197430